SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs-Reference-Cited by-同舟云学术

SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs

Published:2020-11-05 Issue: Volume: Page:1-16
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Bharadwaj Shiv¹^ORCID,Azhar Esam Ibraheem²³,Kamal Mohammad Amjad⁴⁵,Bajrai Leena Hussein³⁶,Dubey Amit⁷,Jha Kanupriya⁸,Yadava Umesh⁹^ORCID,Kang Sang Gu¹^ORCID,Dwivedi Vivek Dhar⁸^ORCID

Affiliation:

1. Department of Biotechnology, Institute of Biotechnology, College of Life and Applied Sciences, Yeungnam University, Gyeongsan, Republic of Korea

2. Medical Laboratory Sciences Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia

3. Special Infectious Agents Unit, King Fahd Medical Research Centre, King Abdulaziz University, Jeddah, Saudi Arabia

4. King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

5. Enzymoics, Novel Global Community Educational Foundation, Hebersham, Australia

6. Biochemistry Department, Faculty of Sciences, King Abdulaziz University, Jeddah, Saudi Arabia

7. Department of Biochemistry, University of Allahabad, Prayagraj, India

8. Center for Bioinformatics, Computational and System Biology, Pathfinder Research and Training Foundation, Greater Noida, India

9. Department of Physics, Deen Dayal Upadhyaya Gorakhpur University, Gorakhpur, India

Funder

The Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1842807

Reference38 articles.

1. Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations

2. Density functional theory and molecular dynamics simulation support Ganoderma lucidum triterpenoids as broad range antagonist of matrix metalloproteinases

3. Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease

4. SARS-CoV-2 Mpro inhibitors: identification of anti-SARS-CoV-2 Mpro compounds from FDA approved drugs

5. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quercetin derivatives as potential inhibitors of Nipah virus phosphoprotein through in silico drug design approaches;Journal of the Indian Chemical Society;2024-08

2. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03

3. Integrating population-level and cell-based signatures for drug repositioning;2023-10-26

4. In silicoidentification of natural compounds against SARS-CoV-2 main protease from Chinese herbal medicines;Future Science OA;2023-08

5. Does digital finance promote the “quantity” and “quality” of green innovation? A dynamic spatial Durbin econometric analysis;Environmental Science and Pollution Research;2023-05-13